AGP Executive Report
Last update: 7 hours agoHemp Ban Fight: The White House and Senate Republicans are clashing over a proposed pause to the upcoming federal ban on many hemp-derived cannabinoid products, with a continuing-resolution provision aimed at delaying the cutoff until Dec. 11—an effort that could keep intoxicating hemp gummies and vapes on shelves longer. State Policy Clash: Rhode Island reopened its cannabis retail licensing application process after court action and new state law reset the rules, with online submissions running through Nov. 23. Public Health Watch: CDC-linked reporting says hospital ER diagnoses of cannabis hyperemesis syndrome rose 16% from last October to May, tied to better tracking after the condition received its own diagnosis code. Youth Vaping Crackdown: In West Virginia, a sheriff says vape-shop raids are driven by school medical emergencies tied to illegal THC products sold to under-21s. Clinical Research: A phase 2 trial found oral semaglutide reduced heavy drinking days in adults with alcohol use disorder, and among participants who used cannabis it also reduced cannabis use days. Seed-to-Sale Tracking: St. Kitts and Nevis launched a seed-to-sale track-and-trace system to monitor its medicinal cannabis supply chain and support licensing and compliance. Business News: New York’s Silly Nice is pushing more hash and full-spectrum concentrates as the regulated market matures.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
